Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT01478048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized Study of Bortezomib/Dexamethasone With or Without Elotuzumab in Subjects With Relapsed/Refractory Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether the addition of Elotuzumab to Bortezomib/ Dexamethasone will prolong the time before myeloma worsens \[progression free survival (PFS)\].
Study identification
- NCT ID
- NCT01478048
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011 (Actual)
- Primary completion
- May 30, 2014 (Actual)
- Completion
- Apr 21, 2017 (Actual)
- Last update posted
- May 21, 2018
2011 – 2017
United States locations
- U.S. sites
- 42
- U.S. states
- 18
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Compassionate Cancer Res Grp | Corona | California | 92879 | — |
| Local Institution | Corona | California | 92879 | — |
| Local Institution | Long Beach | California | 90806 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Ucla Department Of Medicine | Los Angeles | California | 90095 | — |
| Medical Oncology Care Associates | Orange | California | 92868 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Kaiser Permanente Medical Center | Vallejo | California | 94589 | — |
| Local Institution | Vallejo | California | 94589 | — |
| Cancer Specialists of North FL | Jacksonville | Florida | 32256 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33401 | — |
| Kaiser Permanente-Moanalua Medical Center | Honolulu | Hawaii | 96819 | — |
| University Of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Local Institution | Decatur | Illinois | 62526 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Local Institution | Urbana | Illinois | 61801 | — |
| Investigative Clinical Research Of Indiana, Llc | Indianapolis | Indiana | 46260 | — |
| Local Institution | Hazard | Kentucky | 41701 | — |
| University Of Kentucky Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| Pikeville Medical Center Leonard Lawson Cancer Center | Pikeville | Kentucky | 41501 | — |
| Cancer Center Of Acadiana | Lafayette | Louisiana | 70503 | — |
| Local Institution | Shreveport | Louisiana | 71101 | — |
| Local Institution | Baltimore | Maryland | 21204 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Local Institution | Worcester | Massachusetts | 01608 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Mercy Medical Research Institute | Springfield | Missouri | 65807 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| Southern Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Waverly Hematology Oncology | Cary | North Carolina | 27518 | — |
| St. Agnes Hospital | Baltimore | Pennsylvania | 21229 | — |
| Cancer Care Associates | Bethlehem | Pennsylvania | 18015 | — |
| Penn State Hershey Cancer Institute | Hershey | Pennsylvania | 17033 | — |
| Penn State Hershey Cancer Inst | Hershey | Pennsylvania | 17033 | — |
| The Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Medical University Of South Carolina | Charleston | South Carolina | 29425 | — |
| Local Institution | Greenville | South Carolina | 29615 | — |
| Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Northwest Cancer Center | Houston | Texas | 77090 | — |
| Local Institution | Fairfax | Virginia | 22031 | — |
| Local Institution | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01478048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2018 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01478048 live on ClinicalTrials.gov.